HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. - Wikidata - awgldk - TriplyDB

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

http://www.wikidata.org/entity/Q41646662

about

Pathogenesis of human immunodeficiency virus infection Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro Clinical significance of HIV-1 coreceptor usage.Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses HIV-1 Transmission, Replication Fitness and Disease Progression.Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmi Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1 Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.Back to the future: covalent epitope-based HIV vaccine development.HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline Selective transmission of R5 HIV-1 variants: where is the gatekeeper?MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine.Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1

P2860

Q24634681-8BFD98A0-7658-4A1A-B932-A7BEDF01EDA0 Q27480750-0473376A-BD1E-4291-9279-56C18C2244F9 Q27691426-4EE50E47-DE01-4C6E-800D-16A795B0A5B2 Q28378547-DEDE5033-F254-417C-BB3A-2E427E8A4F47 Q29615993-2E455EB4-7D11-4262-AEA6-C80B277E9B48 Q30305455-5410733B-CBF0-497B-90A3-AC81F5689D34 Q30322838-35993429-3F8B-4C33-BA0D-A6A4C51815EE Q33318083-2A2537F6-48B5-49A4-B9FF-3136FB6B336E Q33641854-F3691FDB-A771-4484-AD57-8A4BA4FADA14 Q33719811-7E47B69D-16DC-401D-8EED-5D122CA728D5 Q33736978-3FE01538-BA27-496F-9954-1888D2C46773 Q33758570-85F1C586-930C-46E2-BBA0-BD40F1479091 Q33781934-9D3F16A9-D54D-4284-A69A-EF0D7CC6A9D3 Q33784321-EAA3F569-A11A-4BB9-AAC4-D2E3B7C1A97B Q33785137-E075AF7B-C363-4515-8482-47087FB16289 Q33785473-FC19B303-3D9D-48D6-B6A7-CADDDFF3EFFC Q33786386-F15413E3-8AFE-45F4-9103-FAAD30148BA4 Q33813025-954F37D6-1583-43F9-9AC0-FB2B428B9D61 Q33816465-4040CD08-DD45-44CD-B255-D1608CF39157 Q33842020-24B8B722-8F3D-4AA7-B84C-EBDF9A037698 Q33951977-05CCD6D9-518E-4904-AA0B-81D432095F94 Q33968924-8EC4519E-C703-4A97-9B50-F91EEE5DCC50 Q34010283-F1655189-35E1-4F41-A30C-040E9861E2C2 Q34193190-4DFF1C9B-1391-4665-9087-6DC107794E3D Q34220902-D1C4C8A9-913B-4BD6-A3FB-9793E7918B7C Q34316588-7A3C0279-1E1A-4E7F-8001-BABB8EE9E562 Q34342452-AFD45571-AEA0-4AC3-A65B-A7E2E7FC0CCD Q34597300-2A5D5ACD-971B-416C-A23A-48E06996C08F Q34923915-105D92D1-CE61-4FBE-87D4-292B53948332 Q34949513-A24C6BFC-1910-42A2-AD2E-CE1CE03E7F4D Q35009308-CA01116C-1D64-43B8-AA21-B76DF9F63265 Q35015256-D6098D56-A003-4AAC-80FF-9F6473CCB9C5 Q35018140-8AD33617-EDAA-4C06-8961-D73701B3B19E Q35124100-74CB81E8-149D-4CE9-8323-21DB2D32BD12 Q35127334-295B502C-1476-4C4F-84EB-21CFE8A3B7B5 Q35133895-075486D9-AAF3-4F7E-B918-9332EDFBB172 Q35198556-B3A98A0A-1C71-4859-A252-9495BBED8D47 Q35828529-C6E7A690-F531-4D10-855A-82A5ED22FB11 Q35838430-8ACE5C93-C2B6-4E43-8D77-874930FF6691 Q35839969-5E9A7CAA-3EFC-462A-A4D9-6A5744F6610E

P2860

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

http://www.wikidata.org/entity/Q41646662

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.

@en

type

label

HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.

@en

prefLabel

HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.

@en

P1433

Q41646662-A8C77D6F-1BBE-4132-8410-C27DEADE59D5

P1476

Q41646662-84C1B94E-942B-4452-9AC4-8AD70188C270

P2093

Q41646662-20D0E01D-9318-45B7-BE40-215C2D8CC8B3

Q41646662-3041B117-8126-4A48-8D8F-420EC81B74B2

Q41646662-4D4C4C96-B9EE-4056-B325-963C7769CADD

Q41646662-5868D4D3-042E-4978-9124-424E39C6B625

Q41646662-77A1FDD3-A7FF-4CBA-AC3B-5D3AC81292B3

Q41646662-A1EC5628-21C6-4E23-B017-F0B512292BBF

Q41646662-B741EC11-1AF6-4B8B-BC4B-50AB3CF81DD9

Q41646662-CD9D4E90-6360-4F01-AEDA-C7B79A23AE2C

Q41646662-E1343AAA-40D0-4627-BF1F-9F56BBAB213B

P304

Q41646662-C311DF92-C6F7-4795-A4F4-15F1476536C7

P31

Q41646662-636E722E-6E43-404A-B24A-4A0250B5380F

P407

Q41646662-64D3CA2B-01F6-4E9A-A30C-F1A3F3C92137

P433

Q41646662-73EBD74F-37FA-4611-93D7-55A86EA0931D

P478

Q41646662-95682341-399B-47D8-A236-6E9631B9F874

P577

Q41646662-7C523478-3B78-4C94-9BF2-05C80501A2A6

P698

Q41646662-B2A836D3-A1A5-416B-9A10-29F8D0E2B7F4

P1433

P1476

HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.

@en

P2093

Coutinho RA

http://www.w3.org/2001/XMLSchema#string

Dercksen MW

http://www.w3.org/2001/XMLSchema#string

Keet RP

http://www.w3.org/2001/XMLSchema#string

Koot M

http://www.w3.org/2001/XMLSchema#string

Miedema F

http://www.w3.org/2001/XMLSchema#string

Terpstra FG

http://www.w3.org/2001/XMLSchema#string

Tersmette M

http://www.w3.org/2001/XMLSchema#string

Vos AH

http://www.w3.org/2001/XMLSchema#string

de Goede RE

http://www.w3.org/2001/XMLSchema#string

P304

49-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1543566

http://www.w3.org/2001/XMLSchema#string